Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Herje

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 21, 2018
Frode Manstad-Hulaas, Martin Herje
Lung Cancer (Amsterdam, Netherlands)|December 19, 2016
Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancerTarje Onsøien Halvorsen, Martin Herje, Nina Levin, et al.
Anticancer Research|January 29, 2018
Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node InvolvementChristine D Valan, Jens E Slagsvold, Tarje Onsøien Halvorsen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 21, 2018
Frode Manstad-Hulaas, Martin Herje
Lung Cancer (Amsterdam, Netherlands)|December 19, 2016
Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancerTarje Onsøien Halvorsen, Martin Herje, Nina Levin, et al.
Anticancer Research|January 29, 2018
Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node InvolvementChristine D Valan, Jens E Slagsvold, Tarje Onsøien Halvorsen, et al.
Pageof 1